ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher SRXH Q2 2025 Earnings EPS Loss of 074 and No Revenue Reported Weigh on Sentiment Noah Holdings Q3 2025 Earnings EPS of 326 Reported Amid Revenue Disclosure Gap Stock Declines TKC Q4 2025 Earnings Mixed Performance Amidst Currency Headwinds and Margin Pressures INCY Q1 2026 Earnings EPS Blows Past Estimates Stock Slightly Lower Damora Therapeutics Q1 2026 Earnings WiderThanExpected Loss Despite Stock Gain